Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing <i>Klebsiella pneumoniae</i> Causing Bloodstream Infections in Northern Italy, 2018

Meropenem/Vaborbactam (MEM-VAB) is a novel carbapenem- β-lactamase inhibitor active against KPC-producing Enterobacteria. Herein, we evaluate the incidence of meropenem/vaborbactam-resistance among KPC-producing <i>K. pneumoniae</i> (KPC-Kp) bloodstream infection in a large Italian hospital. Meropen...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Paolo Gaibani, Donatella Lombardo, Linda Bussini, Federica Bovo, Beatrice Munari, Maddalena Giannella, Michele Bartoletti, Pierluigi Viale, Tiziana Lazzarotto, Simone Ambretti
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2021-05-01
Cyfres:	Antibiotics
Pynciau:	critically ill patients porins combination treatment cross-resistance
Mynediad Ar-lein:	https://www.mdpi.com/2079-6382/10/5/536
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!